Daphne Quimi
CIK: 0001543031
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026IPSC
Century Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
74K shares- - Jun 4, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
24.4K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
44K shares- - Jun 5, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
25K shares- - Sep 12, 2024IPSC
Century Therapeutics, Inc.
Purchase(P)Direct5K shares at avg. $1.53$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  IPSC Century Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 74,000 | - | - | Direct |
| Jun 4, 2026 |  AMLX Amylyx Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 24,372 | - | - | Direct |
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 44,000 | - | - | Direct |
| Jun 5, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 25,000 | - | - | Direct |
| Sep 12, 2024 | IPSC Century Therapeutics, Inc. | Purchase(P) | 5,000 | $1.53 | $7,657 | Direct |
1-5 of 5 transactions
About Quimi Daphne
Quimi Daphne (SEC CIK 0001543031) files insider reports with the SEC as Director of Century Therapeutics, Inc. (IPSC) and Director of Amylyx Pharmaceuticals, Inc. (AMLX).
Signal8 holds 5 ownership filings by Quimi Daphne, all Form 4s, filed between Sep 16, 2024 and Jun 12, 2026. Those filings report 5 transactions, from Sep 12, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Quimi Daphne's filings is in CAMBRIDGE, MA.
Recent filings by Quimi Daphne
- Jun 11, 2026: Grant or award of IPSC derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of AMLX derivative securities (Form 4, code A).
- Jun 12, 2025: Grant or award of IPSC derivative securities (Form 4, code A).
- Jun 5, 2025: Grant or award of AMLX derivative securities (Form 4, code A).
- Sep 12, 2024: Open-market purchase of IPSC shares (Form 4, code P).
Other insiders filing for Century Therapeutics, Inc. (IPSC)
- Russotti Gregory
- Carr Douglas, SVP Finance & Operations
- Pfeiffenberger Brent, President and CEO
- Truitt Joseph, Director
- Cowan Chad, Chief Scientific Officer
- Riva Alessandro, Director